See analyst estimates and all valuation multiples for Health & Beauty
| Company | EV | EV/LTM Revenue | EV/LTM EBITDA |
|---|---|---|---|
| $459B | 7.5x | 17.6x | |
| $371B | 4.3x | 15.6x | |
| $245B | 4.7x | 19.5x | |
| $172B | 2.5x | 11.5x | |
| $92.9B | 1.7x | 8.2x | |
| $76.3B | 3.8x | 15.5x | |
| $66.0B | 3.4x | 12.4x | |
| $60.1B | 8.5x | 37.0x | |
| $56.4B | 3.7x | 14.9x | |
| $49.2B | 3.4x | 23.1x | |
| $45.8B | 8.7x | 37.7x | |
| $42.8B | 4.5x | 18.3x | |
| $41.2B | 2.7x | 12.4x | |
| $34.9B | 1.4x | 7.9x | |
| $31.3B | 2.6x | 17.1x | |
| $24.1B | 3.9x | 17.1x | |
| $22.7B | 1.5x | 7.9x | |
| $22.5B | 1.9x | 11.1x | |
| $21.8B | 2.1x | 6.0x | |
| $17.3B | 1.6x | 10.6x | |
| $13.2B | 7.9x | 38.5x | |
| $12.5B | 2.1x | 10.4x | |
| $12.4B | 2.1x | 14.0x | |
| $10.3B | 7.4x | 41.2x | |
| $10.1B | 6.6x | 26.4x | |
| $9.6B | 6.7x | 35.9x | |
| $8.5B | 1.4x | 7.9x | |
| $8.0B | 1.3x | 12.5x | |
| $7.0B | 7.0x | 27.2x | |
| $6.9B | 1.2x | 6.7x | |
| $6.3B | 9.5x | 29.6x | |
| $5.9B | 3.9x | 19.4x | |
| $5.4B | 1.8x | 12.2x | |
| $5.1B | 1.2x | 7.0x | |
| $4.5B | 2.1x | 12.0x | |
| $4.4B | 1.5x | 6.5x | |
| $4.3B | 10.2x | 31.1x | |
| $4.2B | 8.7x | 33.8x | |
| $4.0B | 1.2x | 6.9x | |
| $4.0B | 3.5x | 10.8x | |
| $3.8B | 1.2x | 7.4x | |
| $3.6B | 1.7x | 10.1x | |
| $3.5B | 2.2x | 12.1x | |
| $3.5B | 2.9x | 17.8x | |
| $3.2B | 3.7x | 9.2x | |
| $3.1B | 0.7x | 5.8x | |
| $3.1B | 2.1x | 10.3x | |
| $2.9B | 1.3x | 9.5x | |
| $2.9B | 0.8x | 5.3x | |
| $2.8B | 8.4x | 31.3x | |
| $2.7B | 1.1x | 5.7x | |
| $2.6B | 2.5x | 11.1x | |
| $2.6B | 1.0x | 7.7x | |
| $2.4B | 0.5x | 6.8x | |
| $2.3B | 6.0x | 17.4x | |
| $2.2B | 5.3x | 19.9x | |
| $2.1B | 2.8x | 14.2x | |
| $2.1B | 3.7x | 18.3x | |
| $2.1B | 2.7x | 18.9x | |
| $2.1B | 0.9x | 6.9x | |
| $2.0B | 1.2x | 10.2x | |
| $1.9B | 1.7x | 12.5x | |
| $1.9B | 2.3x | 11.6x | |
| $1.9B | 2.7x | 12.8x | |
| $1.7B | 0.9x | 7.2x | |
| $1.6B | 6.1x | 17.3x | |
| $1.6B | n/a | n/a | |
| $1.5B | 1.2x | 8.3x | |
| $1.5B | 0.7x | 7.8x | |
| $1.4B | 1.8x | 7.4x | |
| $1.3B | 0.7x | 6.2x | |
| $1.3B | 0.6x | 5.8x | |
| $1.1B | 1.5x | 10.1x | |
| $1.1B | 2.6x | 11.7x | |
| $970M | 1.2x | 6.6x | |
| $956M | 0.8x | 7.8x | |
| $951M | 7.6x | 28.5x | |
| $908M | 2.0x | 9.5x | |
| $906M | 3.7x | 53.1x | |
| $732M | 0.2x | 1.7x | |
| $729M | n/a | n/a | |
| $708M | 1.6x | 9.8x | |
| $657M | n/a | n/a | |
| $596M | n/a | n/a | |
| $584M | 0.8x | 6.5x | |
| $573M | 3.3x | 13.1x | |
| $531M | 0.4x | n/a | |
| $517M | 0.7x | 3.5x | |
| $503M | n/a | n/a | |
| $432M | 1.5x | -20.5x | |
| $412M | 2.0x | -44.3x | |
| $383M | n/a | n/a | |
| $379M | 1.4x | 17.3x | |
| $352M | 1.2x | 9.5x | |
| $323M | 0.7x | 8.9x | |
| $310M | 6.0x | 22.8x | |
| $303M | n/a | n/a | |
| $278M | n/a | n/a | |
| $216M | 0.6x | 9.8x | |
| $211M | n/a | n/a | |
| $203M | 1.4x | 6.1x | |
| $200M | 0.4x | 11.6x | |
| $190M | 2.3x | 13.4x | |
| $188M | 1.0x | 9.2x | |
| $174M | 0.8x | 3.7x | |
| $156M | 0.8x | 5.6x | |
| $151M | 0.6x | 6.1x | |
| $139M | 2.2x | 8.1x | |
| $135M | n/a | n/a | |
| $132M | 0.5x | 6.0x | |
| $85.5M | n/a | n/a | |
| $68.2M | 0.3x | 7.1x | |
| $60.7M | 2.3x | 9.7x | |
| $49.3M | n/a | n/a | |
| $45.3M | 1.0x | n/a | |
| $43.2M | n/a | n/a | |
| $41.3M | n/a | n/a | |
| $41.1M | n/a | n/a | |
| $28.3M | n/a | n/a | |
| $27.4M | 2.2x | n/a | |
| $23.9M | n/a | n/a | |
| $20.6M | 1.1x | -12.0x | |
| $19.6M | n/a | n/a | |
| $13.9M | n/a | n/a | |
| $8.5M | n/a | n/a | |
| $7.9M | n/a | n/a | |
| $5.6M | n/a | n/a | |
| $1.0M | n/a | n/a | |
| -$35.3M | -0.1x | -58.8x |
Valuation multiples as of last 12 months (LTM). Financial data powered by Morningstar, Inc.
See analyst estimates and M&A multiples for Health & Beauty